Covaxin can neutralise dreaded double mutant B.1.617 variant; what it means for India [details]

Covaxin can neutralise deadly 617 COVID variant
With the initial scepticism on its safety taken care of long back; a large part of the current resistance towards Covid vaccine has been due to doubts on its efficacy against different variants.
But if the latest, and more importantly, some credible information on Covid vaccine is anything to go by, then Covaxin "can neutralise" the dreaded 'B.1.617' variant.
Dr Anthony FauciReuters
Even though there is data to prove its efficacy against the deadly and highly infectious variant, Dr Anthony Fauci, the White House Chief Medical Adviser on Tuesday also said that they are collecting data on the same on a daily basis.

Related Keywords

India ,Canada ,White House ,District Of Columbia ,United States ,Bharat ,Anthony Fauci ,Anurag Agrawal ,National Institute Of Virology ,Institute Of Genomics ,White House Chief Medical Adviser ,Bharat Biotech ,National Institute ,Integrative Biology ,Dr Anthony Fauci ,Double Mutant ,Covaxin ,B 1 617 Variant ,Second Wave ,Covid India ,இந்தியா ,கனடா ,வெள்ளை வீடு ,மாவட்டம் ஆஃப் கொலம்பியா ,ஒன்றுபட்டது மாநிலங்களில் ,பாரத் ,தேசிய நிறுவனம் ஆஃப் வைராலஜி ,நிறுவனம் ஆஃப் மரபியல் ,பாரத் பயோடெக் ,தேசிய நிறுவனம் ,ஒருங்கிணைந்த உயிரியல் ,இரட்டை விகாரி ,இரண்டாவது அலை ,